|
|
biomarker quantification
|
TMAO, choline, phosphocholine, glycerophosphocholine, betaine, carnitine. |
|
both |
8-20wks |
2021 |
|
|
body weight
|
Body weight |
|
both |
8-20wks |
2021 |
|
|
hormone quantification
|
Insulin, glucose:insulin ratio. |
|
both |
8-20wks |
2021 |
|
|
intake monitoring
|
Food intake; energy intake; protein, carbohydrate, fat intake. |
|
both |
8-20wks |
2021 |
|
|
lipid profile
|
Cholesterol, non-esterified fatty acids, triglyceride. |
|
both |
8-20wks |
2021 |
|
|
metabolic panel
|
Plasma enzymes, creatinine, glucose, urea, metabolic health score. |
|
both |
8-20wks |
2021 |
|
|
monitoring system
|
O2 consumption, CO2 production, RER, heat expenditure, activity. |
|
both |
8-20wks |
2021 |
|
|
MRI
|
Body composition (lean, fat, water). |
|
both |
8-20wks |
2021 |
|
|
body weight
|
Body weight |
CC
|
f |
17-72wks |
2017 |
|
|
MRI
|
Body composition (fat and lean mass and percent). |
CC
|
f |
17-72wks |
2017 |
|
|
treadmill endurance test
|
Maximal distance is recorded when mouse fails to run. |
CC
|
f |
17-72wks |
2017 |
|
|
running wheel monitoring
|
Running wheel activity each day for 28 days. |
CC
|
f |
5-22wks |
2017 |
|
|
body weight
|
Body weight before, during, and after several weeks of exercise. |
CC
|
f |
20-88wks |
2017 |
|
|
intake monitoring
|
Food intake, before, during, and after several weeks of exercise. |
CC
|
f |
20-88wks |
2017 |
|
|
MRI
|
Body composition (fat and lean mass) before, during, and after several weeks of exercise. |
CC
|
f |
20-88wks |
2017 |
|
|
genotyping
|
SNP profiling, 130,000+ genomic locations, 1-19,X,Y,MT. |
CC w/par
|
m |
|
2020 |
|
|
genotyping
|
SNP profiling, 76,000+ genomic locations, 1-19,X,MT |
CC w/par
|
both |
|
2017 |